The impact of platelet-activating factor (PAF)-like mediators on the functional activity of neutrophils: Anti-inflammatory effects of human PAF-acetylhydrolase

Clinical and Experimental Immunology

Volumn 123, Issue 3, 2001, Pages 412-420

  Kuijpers, T W ^a   Van den Berg, J M ^a   Tool, A T J ^a   Roos, D ^a  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Apoptosis inflammation; Chemotaxis; Neutrophils; Platelet activating factor acetyl hydrolase

Indexed keywords

2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE DERIVATIVE; ANTIINFLAMMATORY AGENT; PLACEBO; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME DEGRADATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; NEUTROPHIL CHEMOTAXIS; NORMAL HUMAN; PHAGOCYTE; POLYMERIZATION; PRIORITY JOURNAL;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; CALCIUM; CELL SURVIVAL; CHEMOTAXIS, LEUKOCYTE; CYTOSOL; HUMANS; NADPH OXIDASE; NEUTROPHILS; PHOSPHOLIPASES A; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; RECOMBINANT PROTEINS;

EID: 0035066341     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2001.01483.x     Document Type: Article

References (46)

1. Biochemistry of Platelet-activating Factor: A unique class of biologically active phospholipids
2. Platelet-activating factor: Receptors and signal transduction
3. The role of PAF in endotoxin-related disease
4. Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung
5. Molecular cloning and expression of platelet-activating factor receptor from human leukocytes
6. Characterization of a human cDNA that encodes a functional receptor for platelet activating factor
7. Platelet-activating factor (PAF) positively auto-regulates the expression of human PAF receptor transcript 1 (leukocyte-type) through NF-kappa B
8. Positive and negative regulations of human platelet-activating factor receptor transcript 2 (tissue-type) by estrogen and TGF-beta 1
9. Neutrophil migration across monolayers of cytokine-prestimulated endothelial cells: A role for Platelet-activating Factor and IL-8
10. Intelieukin-1-induced leukocyte extravasation across rat mesenteric microvessels is mediated by platelet-activating factor
11. Chemoattractant signalling and leukocyte activation
12. Common and distinct intracellular signaling pathways in humen neutrophils utilized by platelet-activating factor and FMLP
13. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products
14. Impairment of function in ageing neutrophils is associated with apoptosis
15. Human neutrophils lose their surface FcãRIII and acquire Annexin V binding sites during apoptosis in vitro
16. Regulation of neutrophil apoptosis by tumor-necrosis factor-á: Requirements of TNFR55 and TNFR75 for induction of apoptosis in vitro
17. Mammalian platelet-activating factor acetylhydrolases
18. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase
19. cDNA cloning and expression of intracellular platelet activating factor (PAF) acetylhydrolase II. Its homology with plasma acetylhydrolase
20. Brain acetylhydrolase that inactivates platelet-activating factor is a G-protein-like trimer
21. Complement and immunoglobulins stimulate superoxide production by human leukocytes independently of phagocytosis
22. Purification and cryopreservation of phagocytes from human blood
23. Freezing adhesion molecules in a state of high-avidity binding blocks eosinophil migration
24. Kinetics and mechanism of the bactericidal action of human neutrophils against Escherichia coli
25. Is cytosolic ionized calcium regulating neutrophil activation?
26. 2+ influx: Analysis with indo-1
27. 2+ indicators with greatly improved fluorescence properties
28. Release of platelet-activating factor is important for the respiratory burst induced in human eosinophils by opsonized particles
29. Nimesulide inhibits platelet-activating factor synthesis in activated human neutrophils
30. Granulocyte and granulocytemacrophage colony-stimulating factors exert differential effects on neutrophil platelet-activating factor generation and release
31. Apoptosis in circulating PMN increased susceptibility in L-selectin-deficient PMN
32. Human plasma platelet-activating factor acetylhydrolase. Oxidatively fragmented phospholipids as substrates
33. Platelet-activating factor (PAF) acts as an intercellular messenger in the changes of cytosolic free Ca2+ in human neutrophils induced by opsonized particles
34. Differential responsiveness of human neutrophils to the autocrine actions of 1-O-alkyl-homologs and 1-acyl analogs of platelet-activating factor
35. Novel leukocyte agonists are released by endothelial cells exposed to peroxide
36. Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor
37. Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor
38. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease
39. Evaluations of the safety, pharmacokinetics and clinical pharmacology of recombinant human platelet-activating factor acetylhydrolase in healthy subjects and critically ill patients
40. Vasoactive side effects of intravenous immunoglobulin presss in a rat model and their treatment with recombinant platelet-activating factor acetylhydrolase
41. The cardiopulmonary effects of granulocyte colony-stimulating factor in a canine-model of bacterial sepsis
42. Decreased apoptosis and increased activation of alveolar neutrophils in bacterial pneumonia
43. Modulation of neutrophil apoptosis by granulocyte colony stimulating factor and granulocyte/macrophage colony stimulating factor during the course of acute respiratory distress syndrome
44. An appetite for apoptosis cells?
45. Mechanisms of disease: Tissue desctruction by neutrophils
46. Platelet activating factor acetylhydrolase decreases lung perfusion injury